SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

In-Pharmatechnologist.com joins BASF and Dow at CPhI India

By Gareth Macdonald , 22-Nov-2012
Last updated on 22-Nov-2012 at 19:30 GMT

in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics and Bend Research.

BASF continued the global roll out of its new line of pharma grade Omega-3 APIs in Mumbai. The drug industry conference is the second event at which the firm has showcased its new range of high purity active pharmaceutical ingredients (API) since launching the product in Madrid, Spain in early October.

The firm – which entered the pharma grade omega-3 industry earlier this year with the acquisition of Scotland-based Equateq – has been steadily building this part of its business over the last few months.

And just yesterday BASF tabled a bid for fellow manufacturer Pronova Biopharma yesterday to further expand capacity. If the deal completes, BASF will be involved in supplying several pharmaceutical companies, notably GSK and Amarin.

Dow talks spray drying in India

Dow Wolff Cellulosics, a business unit of The Dow Chemical Company, was also in Mumbai to update on its collaboration with contract formulations developer Bend Research.

The companies teamed up in October to develop effective spray-dried dispersion solutions and a selection of enabling cellulosics polymers to address the challenge of formulating poorly soluble drugs.

Dago Caceres, Global Strategic Marketing Leader for Dow Wolff Cellulosics, said: "Formulation scientists are increasingly in need of reliable and robust technology solutions to overcome this critical drug delivery issue."

"Formulation development economics have gone beyond simply using inexpensive raw materials" continued Caceres, adding "They now require cost assessments for development, scale up and manufacturing."

He also said that: "In India, the scientifically-advanced customer application development centre at Mumbai of Dow Chemical International, is at our customers’ support in the areas of Controlled Release and Immediate Release Technology.”

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

All Gallery

Scottish referendum: we look at Scotland's Nobel drug contributions

Nobel prizes and the world’s top drug: a gallery of Scottish pharma

On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...

Sanofi, Amgen, FDA: All change

Sanofi, Amgen, FDA: All change

Who's in, who's out: all the latest changes in senior pharmaceutical appointments.

Roche director resigns to avoid conflict with Google's Calico

Roche director resigns to avoid conflict of interest with Google's Calico

Plus senior hires at Merck Serono, Astellas, the European Medicines Agency, and more.

Key Industry Events

 

Access all events listing

Our events, Events from partners...